Disclosures

William J. Gradishar, MD, FACP, FASCO

Betty Bramsen Professor of Breast Oncology and Chief, Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

Received clinical research support/data safety monitoring board from Daiichi Sankyo, Genentech, Novartis, and Seattle Genetics

Served on scientific advisory board or as a consultant or expert witness for ambrx, AstraZeneca, Merck & Co, and Pfizer

Prashant Kapoor, MD, FACP

Assistant Professor of Medicine and Oncology (Division of Hematology), Mayo Clinic, Rochester, Minnesota

Served on scientific advisory board or as a consultant or expert witness for BeiGene, Pharmacyclics, X4 Pharmaceuticals, Oncopeptides, Angitia Bio, GSK, AbbVie, and Sanofi

Received research funding from Amgen, Regeneron, Bristol Myers Squibb, Loxo Pharmaceuticals, Ichnos, Karyopharm, Sanofi, AbbVie, and GSK

Shaji K. Kumar, MD

Professor of Medicine, Mayo Clinic, Rochester, Minnesota

Received clinical research support/data safety monitoring board from AbbVie, Allogene, Arcellx, Bristol Myers Squibb, Carsgen, GlaxoSmithKline, MedImmune, Oncopeptides, Roche Laboratories, and Takeda Pharmaceuticals North America

Served on scientific advisory board or as a consultant or expert witness for AbbVie, BeiGene, Bluebird, Bristol Myers Squibb, Epizyme, GlaxoSmithKline, GLH Pharma, Oncopeptides, Pfizer, Regeneron Pharmaceuticals, Roche Laboratories, sanofi-aventis US, Secura, Takeda Pharmaceuticals North America, and Trillium

Soo Park, MD

Associate Professor, Division of Hematology/Oncology, UC San Diego Moores Cancer Center,
San Diego, California

Received clinical research support/data safety monitoring board from Regeneron Pharmaceuticals

Served on scientific advisory board or as a consultant or expert witness for Regeneron Pharmaceuticals

Gregory J. Riely, MD, PhD

Vice Chair of Clinical Research, Department of Medicine, Memorial Sloan Kettering Cancer Center,
New York, New York

Received clinical research support/data safety monitoring board from Amgen, Chugai, Eli Lilly and Company, Genentech, Merck & Co., Mirati, Novartis Pharmaceuticals, Pfizer, Rain Therapeutics, and Takeda Pharmaceuticals North America

Served on scientific advisory board or as a consultant or expert witness for AstraZeneca Pharmaceuticals LP, Bayer HealthCare, Merck & Co., Mirati, Novartis Pharmaceuticals, Pfizer, and Takeda Pharmaceuticals North America

Medical Writers:

The following medical writers reported no conflicts of interest.

Jenna Carter, PhD; Vanessa A. Carter, BS; Celeste L. Dixon; Anna Fanelli; Julia Cipriano, MS; Joseph Cupolo, MS; Bryna Goeking; Justine Landin, PhD; Sarah Lynch; Victoria Kuhr, MS; Amy MacDonald, MS; Joshua Madera, MD; Margie Miller; Susan Reckling, MA; Kayci Reyer; Emily Rhodes; Amanda E. Ruffino, BA; Chris Schimpf, MSW; Joshua Swore, PhD